Clinical trials
Alzheimer Disease trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 4 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Axovant Sciences Ltd. | 2 |
| Duke-NUS Graduate Medical School | 2 |
| Eli Lilly and Company | 2 |
| National University Hospital, Singapore | 2 |
| TauRx Therapeutics Ltd | 2 |
| Bristol-Myers Squibb | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Eisai Inc. | 1 |
| Eisai Korea Inc. | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 26 |
| Dementia | 9 |
| Cognitive Dysfunction | 8 |
| Brain Diseases | 4 |
| Neurodegenerative Diseases | 4 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis | 1 |
| Anxiety Disorders | 1 |
| Cardiomyopathies | 1 |
| Central Nervous System Diseases | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.